Therefore, this study posits that Srxn1 exerts anti‐inflammatory and antioxidant effects by targeting the TLR4/NF‐κB signalling pathway, thereby improving pathological myocardial remodelling after HF. Here, NFKB1 is linked to hydrops fetalis.